Real-world Comparative Effectiveness of Tocilizumab Monotherapy vs. Tumor Necrosis Factor Inhibitors with Methotrexate in Patients with Rheumatoid Arthritis

por Harrold, Leslie R., Reed, George W., Best, Jennie, Zlotnick, Steve, Kremer, Joel M.
Publicado 2018

Patients’ knowledge and beliefs concerning gout and its treatment: a population based study

por Harrold, Leslie R, Mazor, Kathleen M, Peterson, Daniel, Naz, Nausheen, Firneno, Cassandra, Yood, Robert A
Publicado 2012

What Outcomes are Important for Gout Patients? In-Depth Qualitative Research into the Gout Patient Experience to Determine Optimal Endpoints for Evaluating Therapeutic Intervention...

por Tatlock, Sophi, Rüdell, Katja, Panter, Charlotte, Arbuckle, Rob, Harrold, Leslie R., Taylor, William J., Symonds, Tara
Publicado 2016

Time‐Varying Association of Rheumatoid Arthritis Disease Activity to Subsequent Cardiovascular Risk

por Yoshida, Kazuki, Harrold, Leslie R., Middaugh, Nicole, Guan, Hongshu, Stryker, Scott, Karis, Elaine, Solomon, Daniel H.
Publicado 2022

Comparative Effectiveness of Abatacept vs. Tofacitinib in Rheumatoid Arthritis Patients who are CCP+

por Harrold, Leslie R., Wittstock, Keith, Kelly, Sheila, Han, Xue, Shan, Ying, Guo, Lin, Moore, Page C., Khaychuk, Vadim
Publicado 2023

Comparative effectiveness and safety of rituximab versus subsequent anti–tumor necrosis factor therapy in patients with rheumatoid arthritis with prior exposure to anti–tumor necro...

por Harrold, Leslie R., Reed, George W., Magner, Robert, Shewade, Ashwini, John, Ani, Greenberg, Jeffrey D., Kremer, Joel M.
Publicado 2015

Adherence with urate-lowering therapies for the treatment of gout

por Harrold, Leslie R, Andrade, Susan E, Briesacher, Becky A, Raebel, Marsha A, Fouayzi, Hassan, Yood, Robert A, Ockene, Ira S
Publicado 2009

Risk of Infection Associated With Subsequent Biologic Agent Use After Rituximab: Results From a National Rheumatoid Arthritis Patient Registry

por Harrold, Leslie R., Reed, George W., Karki, Chitra, Magner, Robert, Shewade, Ashwini, John, Ani, Kremer, Joel M., Greenberg, Jeffrey D.
Publicado 2016

Comparative effectiveness of abatacept versus tocilizumab in rheumatoid arthritis patients with prior TNFi exposure in the US Corrona registry

por Harrold, Leslie R., Reed, George W., Solomon, Daniel H., Curtis, Jeffrey R., Liu, Mei, Greenberg, Jeffrey D., Kremer, Joel M.
Publicado 2016

Impact of rituximab on patient-reported outcomes in patients with rheumatoid arthritis from the US Corrona Registry

por Harrold, Leslie R., John, Ani, Best, Jennie, Zlotnick, Steve, Karki, Chitra, Li, YouFu, Greenberg, Jeffrey D., Kremer, Joel M.
Publicado 2017

Comparative Effectiveness of Abatacept Versus Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid Arthritis Who Are Anti-CCP Positive in the United States Corrona Registry

por Harrold, Leslie R., Litman, Heather J., Connolly, Sean E., Alemao, Evo, Kelly, Sheila, Rebello, Sabrina, Hua, Winnie, Kremer, Joel M.
Publicado 2019

The comparative effectiveness of abatacept versus anti-tumour necrosis factor switching for rheumatoid arthritis patients previously treated with an anti-tumour necrosis factor

por Harrold, Leslie R, Reed, George W, Kremer, Joel M, Curtis, Jeffrey R, Solomon, Daniel H, Hochberg, Marc C, Greenberg, Jeffrey D
Publicado 2015

A window of opportunity for abatacept in RA: is disease duration an independent predictor of low disease activity/remission in clinical practice?

por Harrold, Leslie R., Litman, Heather J., Connolly, Sean E., Kelly, Sheila, Hua, Winnie, Alemao, Evo, Rosenblatt, Lisa, Rebello, Sabrina, Kremer, Joel M.
Publicado 2017

Prevalence of Sjögren’s syndrome associated with rheumatoid arthritis in the USA: an observational study from the Corrona registry

por Harrold, Leslie R., Shan, Ying, Rebello, Sabrina, Kramer, Neil, Connolly, Sean E., Alemao, Evo, Kelly, Sheila, Kremer, Joel M., Rosenstein, Elliot D.
Publicado 2020

Disease activity and patient-reported outcomes in patients with rheumatoid arthritis and Sjögren’s syndrome enrolled in a large observational US registry

por Harrold, Leslie R., Shan, Ying, Rebello, Sabrina, Kramer, Neil, Connolly, Sean E., Alemao, Evo, Kelly, Sheila, Kremer, Joel M., Rosenstein, Elliot D.
Publicado 2020

Unmet Medical Needs in the Treatment and Management of Generalized Pustular Psoriasis Flares: Evidence from a Survey of Corrona Registry Dermatologists

por Strober, Bruce, Kotowsky, Nirali, Medeiros, Rose, Mackey, Rachel H., Harrold, Leslie R., Valdecantos, Wendell C., Flack, Mary, Golembesky, Amanda K., Lebwohl, Mark
Publicado 2021

Baseline Anti-Citrullinated Protein Antibody Status and Response to Abatacept or Non-TNFi Biologic/Targeted-Synthetic DMARDs: US Observational Study of Patients with RA

por Harrold, Leslie R., Connolly, Sean E., Wittstock, Keith, Zhuo, Joe, Kelly, Sheila, Lehman, Thomas, Shan, Ying, Rebello, Sabrina, Guo, Lin, Khaychuk, Vadim
Publicado 2021

Rheumatologist and Patient Mental Models for Treatment of Rheumatoid Arthritis Help Explain Low Treat‐to‐Target Rates

por Hsiao, Betty, Downs, Julie, Lanyon, Mandy, Blalock, Susan J., Curtis, Jeffrey R., Harrold, Leslie R., Nowell, William Benjamin, Wiedmeyer, Carole, Venkatachalam, Shilpa, Fraenkel, Liana
Publicado 2022

Impact of Tocilizumab Monotherapy on Clinical and Patient-Reported Quality-of-Life Outcomes in Patients with Rheumatoid Arthritis

por Harrold, Leslie R., John, Ani, Reed, George W., Haselkorn, Tmirah, Karki, Chitra, Li, YouFu, Best, Jennie, Zlotnick, Steve, Kremer, Joel M., Greenberg, Jeffrey D.
Publicado 2017

Association Between Baseline Anti-cyclic Citrullinated Peptide Antibodies and 6-Month Clinical Response Following Abatacept or TNF Inhibitor Treatment: A Real-World Analysis of Bio...

por Harrold, Leslie R., Bryson, Joshua, Lehman, Thomas, Zhuo, Joe, Gao, Sheng, Han, Xue, Schrader, Amy, Rebello, Sabrina, Pappas, Dimitrios A., Sommers, Tanya, Kremer, Joel M.
Publicado 2021